BRCA2 and breast cancer: Compared to other BRCA2 mutations, OCCR mutations are associated with higher ovarian cancer risk (RR=1.88; 95% CI 1.08–3.33) and lower breast cancer risk (RR=0.63; 95% CI 0.46–0.84) (Thompson and Easton, 2001).